ArticleJournal for immunotherapy of cancer2021

Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer.

Patricia Rich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.